SUVENPHAR.BOSUVENPHAR.BOBSE
Loading
Cost of Revenue Over TimeStable
Percentile Rank50
3Y CAGR-13.2%
5Y CAGR+2.4%
Studio
Year-over-Year Change

Direct costs attributable to producing goods sold

3Y CAGR
-13.2%/yr
Annual compound
5Y CAGR
+2.4%/yr
Recent deceleration
Percentile
P50
Within normal range
vs 5Y Ago
1.1x
Modest growth
Streak
1 yr
Consecutive growthStable
PeriodValueYoY Change
2025$3.76B+1.1%
2024$3.72B-36.8%
2023$5.88B+2.5%
2022$5.74B+31.3%
2021$4.37B+30.8%
2020$3.34B-10.3%
2019$3.73B-